These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. From Activated Partial Thromboplastin Time to Antifactor Xa and Back Again. May JE; Siniard RC; Taylor LJ; Marques MB; Gangaraju R Am J Clin Pathol; 2022 Mar; 157(3):321-327. PubMed ID: 34562001 [TBL] [Abstract][Full Text] [Related]
28. Comparison of anti-Xa and activated partial thromboplastin time monitoring for heparin dosing in patients with cirrhosis. Fuentes A; Gordon-Burroughs S; Hall JB; Putney DR; Monsour HP Ther Drug Monit; 2015 Feb; 37(1):40-4. PubMed ID: 24901494 [TBL] [Abstract][Full Text] [Related]
29. Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin. Wahking RA; Hargreaves RH; Lockwood SM; Haskell SK; Davis KW Ann Pharmacother; 2019 Aug; 53(8):801-805. PubMed ID: 30813751 [No Abstract] [Full Text] [Related]
30. Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time. Coons JC; Iasella CJ; Thornberg M; Fitzmaurice MG; Goehring K; Jablonski L; Leader D; Meyer A; Seo H; Benedict NJ; Smith RE Am J Hematol; 2019 Sep; 94(9):1015-1019. PubMed ID: 31243789 [TBL] [Abstract][Full Text] [Related]
31. Establishing a new target range for unfractionated heparin for acute coronary syndromes. Lee MS; Menon V; Schappert J; Wilentz JR; Singh V; Hochman JS J Thromb Thrombolysis; 2004 Apr; 17(2):121-6. PubMed ID: 15306747 [TBL] [Abstract][Full Text] [Related]
33. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
34. Comparison of unfractionated heparin protocols using antifactor Xa monitoring or activated partial thrombin time monitoring. Frugé KS; Lee YR Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S90-7. PubMed ID: 26272899 [TBL] [Abstract][Full Text] [Related]
35. Monitoring heparin anticoagulation in the acute phase response. Uprichard J; Manning RA; Laffan MA Br J Haematol; 2010 May; 149(4):613-9. PubMed ID: 20230412 [TBL] [Abstract][Full Text] [Related]
36. Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices. Adatya S; Sunny R; Fitzpatrick MJ; Colvin M; Thennapan T; John R; Dodge Zantek N; Pritzker M; Eckman P; Uriel N J Heart Lung Transplant; 2016 Nov; 35(11):1311-1320. PubMed ID: 27836023 [TBL] [Abstract][Full Text] [Related]
37. Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents. Smahi M; De Pooter N; Hollestelle MJ; Toulon P J Thromb Haemost; 2020 Oct; 18(10):2613-2621. PubMed ID: 32573889 [TBL] [Abstract][Full Text] [Related]
38. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?]. Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577 [TBL] [Abstract][Full Text] [Related]
39. Retrospective cohort study comparing activated partial thromboplastin time versus anti-factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics. Trucco M; Lehmann CU; Mollenkopf N; Streiff MB; Takemoto CM J Thromb Haemost; 2015 May; 13(5):788-94. PubMed ID: 25740425 [TBL] [Abstract][Full Text] [Related]
40. Anti-activated factor II assay for monitoring unfractionated heparin in children: results of the HEARTCAT study. Hanslik A; Kitzmüller E; Tran US; Thom K; Karapetian H; Prutsch N; Voitl J; Michel-Behnke I; Newall F; Male C J Thromb Haemost; 2017 Jan; 15(1):38-46. PubMed ID: 27736032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]